Publicaciones en las que colabora con M. Luisa Vargas Alvarez Castellanos (25)

2009

  1. Effects of rolipram and diazepam on the adaptive changes induced by morphine withdrawal in the hypothalamic paraventricular nucleus

    European Journal of Pharmacology, Vol. 620, Núm. 1-3, pp. 1-8

1997

  1. Neurochemical activity of noradrenergic neurons and pituitary-adrenal response after naloxone induced withdrawal: The role of calcium channels

    Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 355, Núm. 4, pp. 501-506

1996

  1. Chronic naloxone-induced supersensitivity affects neither tolerance to nor physical dependence on morphine at hypothalamus-pituitary-adrenocortical axis

    Neuropeptides, Vol. 30, Núm. 1, pp. 29-36

1994

  1. Catecholaminergic mediation of morphine-induced activation of pituitary-adrenocortical axis in the rat: implication of α- and β-adrenoceptors

    Brain Research, Vol. 668, Núm. 1-2, pp. 122-128

  2. Effects of intracerebroventricular clonidine on the hypothalamic noradrenaline and plasma corticosterone levels of opiate naive rats and after naloxone-induced withdrawal

    Brain Research, Vol. 647, Núm. 2, pp. 199-203

  3. Lack of involvement of δ-opioid receptor in mediating physical dependence at the hypothalamus-pituitary-adrenocortical (HPA) axis in the rat

    General Pharmacology, Vol. 25, Núm. 4, pp. 719-723

  4. Modulation by catecholamine of hypothalamus-pituitary-adrenocortical (HPA) axis activity in morphine-tolerance and withdrawal

    General Pharmacology, Vol. 25, Núm. 1, pp. 187-192

1993

  1. Chronic kappa opioid receptor antagonism produces supersensitivity to U- 50,488H at the hypothalamo-pituitary-adrenocortical (HPA) axis level

    Journal of Pharmacology and Experimental Therapeutics, Vol. 266, Núm. 3, pp. 1385-1389

  2. Chronic naloxone treatment induces supersensitivity to a mu but not to a kappa agonist at the hypothalamus-pituitary-adrenocortical axis level

    Journal of Pharmacology and Experimental Therapeutics, Vol. 266, Núm. 3, pp. 1602-1606

  3. L-type Ca2+ channel ligands modulate morphine effects on the hypothalamus-pituitary-adrenocortical axis in rats

    European Journal of Pharmacology, Vol. 232, Núm. 2-3, pp. 191-198

  4. Simultaneous changes in hypothalamic catecholamine levels and plasma corticosterone concentration in the rat after acute morphine and during tolerance

    Neuropeptides, Vol. 24, Núm. 5, pp. 279-284

1992

  1. Effects of clonidine on pituitary-adrenocortical axis in morphine-tolerant rats and after naloxone-induced withdrawal

    Pharmacology, Vol. 44, Núm. 3, pp. 158-164

1991

  1. Effects of acute and chronic administration of μ- and δ-opeoid agonists on the hypothalamic-pituitary-adrenocortical (HPA) axis in the rat

    European Journal of Pharmacology, Vol. 200, Núm. 1, pp. 155-158

  2. Influence of stress in the effects of morphine on pituitary-adrenocortical activity in the guinea-pig

    General Pharmacology, Vol. 22, Núm. 2, pp. 223-226

  3. Pituitary-adrenocortical response to acute and chronic administration of U-50 488H in the rat

    Neuropeptides, Vol. 20, Núm. 2, pp. 95-102

1990

  1. Effects of U-50,488H on plasma levels of B-endorphin and cortisol in the rat

    European Journal of Pharmacology

  2. Stress and morphine mediated changes in pituitary-adrenal axis in guinea-pigs

    General Pharmacology, Vol. 21, Núm. 4, pp. 569-571

1989

  1. Influence of Dopaminergic and Noradrenergic Systems on the Release of Opioid Peptides in Guinea‐pig Ileum

    Journal of Pharmacy and Pharmacology, Vol. 41, Núm. 9, pp. 607-611

1987

  1. Effect of selective monoamine oxidase inhibitors on the morphine-induced hypothermia in restrained rats

    General Pharmacology, Vol. 18, Núm. 2, pp. 185-188

  2. Effects of droperidol on the biosynthesis and release of endogenous opioid peptides in guinea-pig ileum

    General Pharmacology, Vol. 18, Núm. 3, pp. 283-286